Eli Lilly and Company

Eli Lilly and Companyverified

LLY

Price:

$885.01

Market Cap:

$841.12B

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various he...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1972-06-01

Stock Exchange

NYSE

Ticker

LLY

The ROE as of June 2024 (TTM) for Eli Lilly and Company (LLY) is 53.53%

According to Eli Lilly and Company’s latest financial reports and current stock price. The company's current ROE is 53.53%. This represents a change of 302.04% compared to the average of 13.31% of the last 4 quarters.

Eli Lilly and Company (LLY) Historical ROE (quarterly & annually)

How has LLY ROE performed in the past?

The mean historical ROE of Eli Lilly and Company over the last ten years is 53.99%. The current 53.53% ROE has changed -0.85% with respect to the historical average. Over the past ten years (40 quarters), LLY's ROE was at its highest in in the March 2019 quarter at 171.01%. The ROE was at its lowest in in the December 2017 quarter at -14.29%.

Quarterly (TTM)
Annual

Average

53.99%

Median

40.77%

Minimum

-1.76%

Maximum

177.91%

Eli Lilly and Company (LLY) ROE by Quarter and Year

Discovering the peaks and valleys of Eli Lilly and Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 441.03%

Maximum Annual ROE = 177.91%

Minimum Annual Increase = -1967.66%

Minimum Annual ROE = -1.76%

Quarterly (TTM)
Annual
YearROEChange
202348.65%-17.03%
202258.64%-5.67%
202162.16%-43.38%
2020109.79%-38.29%
2019177.91%441.03%
201832.88%-1967.66%
2017-1.76%-109.01%
201619.54%18.24%
201516.53%6.29%
201415.55%-41.48%

Eli Lilly and Company (LLY) Average ROE

How has LLY ROE performed in the past?

The current ROE of Eli Lilly and Company (LLY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

56.48%

5-year avg

91.43%

10-year avg

53.99%

Eli Lilly and Company (LLY) ROE vs. Peers

How is LLY’s ROE compared to its peers?

Eli Lilly and Company’s ROE is less than Johnson & Johnson (53.97%), greater than Bristol-Myers Squibb Company (-23.01%), less than AbbVie Inc. (55.33%), greater than Pfizer Inc. (-0.31%), less than Merck & Co., Inc. (5.84%), less than Amgen Inc. (58.59%), less than Gilead Sciences, Inc. (2.32%),

CompanyROEMarket cap
53.97%$351.25B
-23.01%$83.05B
55.33%$299.63B
-0.31%$152.88B
5.84%$322.93B
58.59%$162.69B
2.32%$80.07B

Build a custom stock screener for Eli Lilly and Company (LLY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eli Lilly and Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eli Lilly and Company (LLY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eli Lilly and Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Eli Lilly and Company's ROE?

How is the ROE calculated for Eli Lilly and Company (LLY)?

What is the highest ROE for Eli Lilly and Company (LLY)?

What is the 3-year average ROE for Eli Lilly and Company (LLY)?

What is the 5-year average ROE for Eli Lilly and Company (LLY)?

How does the current ROE for Eli Lilly and Company (LLY) compare to its historical average?